OPTIYIELD - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
78246337
Word Mark
OPTIYIELD
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2004-06-15
Filing Date
2003-05-06
Mark Drawing
1000 - Typeset: Word(s)/letter(s)/number(s)
Typeset
Attorney Name
Law Office Assigned Location Code
L60
Employee Name
WELLS, CHRISTOPHER WIL
Statements
Goods and Services
Reagents for clinical medical use; Reagents for clinical medical use in binding assays, namely assays to detect nucleic acid sequences; Reagents for clinical medical use in binding assays, namely assays to purify nucleic acid sequences; Reagents for clinical medical use in binding assays, namely assays to separate nucleic acid sequences; Reagents for clinical medical use in hybridization assays, namely assays to detect nucleic acid sequences; Reagents for clinical medical use in hybridization assays, namely assays to purify nucleic acid sequences; Reagents for clinical medical use in hybridization assays, namely assays to separate nucleic acid sequences; Reagents for clinical medical use in diagnostic electrophoresis assays; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect analytes; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to purify analytes; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to separate analytes; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect nucleic acid sequences; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to purify nucleic acid sequences; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to separate nucleic acid sequences; Reagents for clinical medical use in electrophoresis assays, namely assays to detect contamination in food products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect contamination in blood products; Reagents for clinical medical use in electrophoresis assays, namely assays to detect biological contamination; Reagents for clinical medical use in electrophoresis assays, namely assays to detect biological contamination in food products; Reagents for clinical medical use in electrophoresis assays, namely assays to detect contamination in blood products; Reagents for clinical medical use in electrophoresis assays, namely assays to detect pathogenic contamination; Reagents for clinical medical use in electrophoresis assays, namely assays to detect food contamination; Reagents for clinical medical use in electrophoresis assays, namely assays to detect blood contamination; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect bacterial contamination in blood products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect viral contamination in blood products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect contamination in platelet products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect bacterial contamination in platelet products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to identify bacterial pathogens in platelet products; Reagent kits comprised of reagents for clinical medical use; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect analytes; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to purify analytes; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to separate analytes; Reagent kits comprised of reagents for clinical medical use, namely assays to detect nucleic acid sequences; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to purify nucleic acid sequences; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to separate nucleic acid sequences; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect contamination in blood products; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect bacterial contamination in blood products; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect viral contamination in blood products; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect contamination in platelet products; Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to detect bacterial contamination in platelet products; and Reagent kits comprised of reagents for clinical medical use in diagnostic electrophoresis assays, namely assays to identify bacterial pathogens
Pseudo Mark
OPTIMUM YIELD
Classification Information
International Class
5 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2003-05-14
Primary Code
005
Correspondences
Name
ANDREW F. ABRAMSON
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2003-08-06 | PAPER RECEIVED |
2003-10-02 | ASSIGNED TO EXAMINER |
2003-10-14 | NON-FINAL ACTION MAILED |
2003-11-17 | PAPER RECEIVED |
2003-11-17 | UNRESPONSIVE/DUPLICATE PAPER RECEIVED |
2004-06-15 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |